The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis
Dick van Soolingen, Rogelio Hernandez-Pando, Hector Orozco et al. · 2010
Read The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis by Dick van Soolingen, Rogelio Hernandez-Pando, Hector Orozco et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012640.txt.
Description
Van Soolingen, Hernandez-Pando, Orozco and co-authors revived an old drug idea against drug-resistant tuberculosis. Some TB bacteria now resist the main drugs, and few replacements are close to ready. Their 2010 study tested thioridazine, a mental-health drug long known to kill TB bacteria in the lab.
In mice infected with resistant TB, the drug showed real promise as a treatment. Reusing an approved drug can reach patients far faster than building a new one. The work gives clinics in poor regions a possible extra weapon against a growing threat.
Catalog record
| CREATOR | Dick van Soolingen, Rogelio Hernandez-Pando, Hector Orozco et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012640